Home › Endometrial Cancer › NCT07527143

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Who can join

Ages 45 and older · Women · Healthy volunteers welcome

Inclusion Criteria:

* Self-identified Black individuals ≥ 45 years with an intact uterus
* Assigned female sex at birth
* Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
* Willing to participate in a 45-minute virtual interview

Exclusion Criteria:

* Previous or current diagnosis of endometrial cancer

About the study

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

What is being tested

• Non-Interventional Study (other)

Sponsor: Mayo Clinic · Participants: 25 · Started: Jun 10, 2026

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015
• Kelly Gunderson · Phone: 507-422-1892

Official record on ClinicalTrials.gov — NCT07527143

Locations in the U.S.

Conditions

• Endometrial Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.